Sort
39,280 grants matching “leukemia”
Elucidating ligand-receptor interactions required for Plasmodium vivax blood-stage infection
$398,750Manoj T Duraisingh · Harvard School Of Public Health · R01 · FY2022 · AI
Elucidating ligand-receptor interactions required for Plasmodium vivax blood-stage infection
$398,750Manoj T Duraisingh · Harvard School Of Public Health · R01 · FY2018 · AI
Elucidating ligand-receptor interactions required for Plasmodium vivax blood-stage infection
$398,750Manoj T Duraisingh · Harvard School Of Public Health · R01 · FY2019 · AI
Embryonic hematopoietic stem cell origin and ontogeny
$398,750University Of Rochester · R01 · FY2004 · DK
Embryonic hematopoietic stem cell origin and ontogeny
$398,750University Of Rochester · R01 · FY2003 · DK
Elucidating ligand-receptor interactions required for Plasmodium vivax blood-stage infection
$398,750Manoj T Duraisingh · Harvard School Of Public Health · R01 · FY2020 · AI
Embryonic hematopoietic stem cell origin and ontogeny
$398,750University Of Rochester · R01 · FY2002 · DK
Identification of stromal responses during castration-induced thymic regrowth.
$398,725Howard T. Petrie · Scripps Research Institute, The · R01 · FY2009 · AG
Discovery of Drugs, Targets, and Target Strategies for Immunotherapy of CLL
$398,717Christoph Rader · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Antibody Engineering for Therapy and Diagnosis of Hematologic Malignancies
$398,717Christoph Rader · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
The Role Of CREB In Leukemogenesis
$398,712Kathleen Miho Sakamoto · University Of California Los Angeles · R01 · FY2006 · HL
MicroRNAs'Role in Hematopoietic Lineage Differentiation
$398,690Stanford University · R01 · FY2005 · HL
GENE EXPRESSION PROFILE OF PROGRESSION &RESPONSE IN CML
$398,689Fred Hutchinson Cancer Research Center · U01 · FY2003 · CA
Role of TRAF6 in Myelodysplastic Syndromes
$398,642Daniel Starczynowski · Cincinnati Childrens Hosp Med Ctr · R01 · FY2014 · HL
Targeted activation of autoimmune checkpoints in B cell malignancies
$398,548Markus Mãschen · Beckman Research Institute/City Of Hope · R01 · FY2019 · CA
The impact of chromosome 17p lesions on leukemogeneis and therapy response
$398,509Scott W Lowe · Sloan-Kettering Inst Can Research · R01 · FY2019 · CA
Mechanisms of Virus Entry into Cells and Antiviral Barriers Limiting Entry
$398,491Alex Compton · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Molecular Pathogenesis & Therapy of JAK2 V617F-induced Myeloproliferative Disease
$398,475Richard A. Van Etten · Tufts Medical Center · R01 · FY2012 · HL
HLS- A Phase 1 Open-Label Dose-Escalation with Expansion Study of SX-682 in MDS Patients
$398,444Stuart J Kahn · Syntrix Biosystems, Inc. · R44 · FY2018 · HL
Mapping Cancer Metabolism by Mid-infrared Photothermal Microscopy
$398,440Ji-Xin Cheng · Boston University (Charles River Campus) · R33 · FY2021 · CA
RNAi Analysis and Screening for Study of Genes and Anti-Cancer Treatments
$398,419Natasha Caplen · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Computational and Experimental Analysis of Vertebrate RNA Splicing
$398,398Christopher B Burge · Massachusetts Institute Of Technology · R01 · FY2009 · HG
Chemoresistance and Stem Cell Selection
$398,382David A Williams · Boston Children'S Hospital · R01 · FY2010 · DK
Role of TRAF6 in Myelodysplastic Syndromes
$398,308Daniel Starczynowski · Cincinnati Childrens Hosp Med Ctr · R01 · FY2016 · HL
Small Molecule Activators of Pro-apoptotic BAX for Cancer Therapy
$398,307Evripidis Gavathiotis · Albert Einstein College Of Medicine · R01 · FY2020 · CA